<DOC>
	<DOCNO>NCT01720485</DOCNO>
	<brief_summary>The purpose study evaluate non-inferiority clinical efficacy two different drug association treatment Moderate - Severe Persistent Allergic Rhinitis Adults .</brief_summary>
	<brief_title>Comparison Desloratadine Associated With Prednisolone ( Tablet ) Versus Dexchlorpheniramine Associated With Betamethasone ( Tablet ) Adult Persistent Allergic Rhinitis Treatment</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Dexchlorpheniramine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Signed Consent patient ; Clinical diagnosis moderate severe persistent allergic rhinitis accord ARIA classification ( Allergic Rhinitis Its Impact Asthma ) ; Adults age â‰¥ 18 year old ; Evidence sensitization aeroallergens examination ( immediate skin test serum specific IgE ) 12 month prior inclusion . Decongestants dependent patient patient receive allergen specific immunotherapy ; Patients use oral antihistamine decongestant past 15 day ; Patients treat systemic corticosteroid last month ; Patients treatment monoamine oxidase inhibitor ( MAOIs ) ; Patients history hypersensitivity formula compound ; Patients clinically significant disease investigator opinion participate study Patients uncontrolled asthma , chronic sinusitis , drug relate rhinitis nasal anatomic abnormality . Participation clinical trial 30 day prior study entry ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>